PTC Therapeutics, Inc. SEC filings PTCT
PTC Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 5, 2017. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 21, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 28, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 13, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jul 30, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Other events
|
Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 2, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2026 | Apr 28, 2026 |
| ARS | Annual report to shareholders | Apr 20, 2026 | Jan 31, 2026 |
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 25, 2026 | Mar 24, 2026 |
| 10-K | Annual report | Feb 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 19, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement
|
Dec 29, 2025 | Dec 29, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| CORRESP | Letter to the SEC | Sep 18, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 21, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 19, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 7, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2025 | Jun 17, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 5, 2025 | May 5, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 28, 2025 | Mar 28, 2025 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 2, 2024 | Nov 27, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 27, 2024 | Nov 26, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2024 | Oct 18, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 28, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Material agreement, Shareholder vote results, Regulation FD disclosure
|
Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2024 | May 20, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 18, 2024 |
| 10-Q | Quarterly report | Apr 25, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 25, 2024 | Apr 25, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| POSASR | Filing | Nov 7, 2023 | — |
| 10-Q | Quarterly report | Oct 26, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 26, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Agreement ended
|
Oct 19, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 19, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Sep 28, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Other events
|
Sep 22, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 15, 2023 | Sep 15, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 19, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2023 | Jul 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
|
May 23, 2023 | May 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 17, 2023 | May 17, 2023 |
| D | Filing | May 8, 2023 | — |
| S-3ASR | Automatic shelf registration | May 5, 2023 | — |
| POSASR | Filing | Apr 28, 2023 | — |
| 10-Q | Quarterly report | Apr 27, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 27, 2023 | Apr 27, 2023 |
| ARS | Annual report to shareholders | Apr 26, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Apr 18, 2023 | Apr 18, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 24, 2023 | Mar 22, 2023 |
| 10-K/A | Amended annual report | Mar 8, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 21, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| S-8 | Employee stock plan registration | Dec 16, 2022 | — |
| S-3ASR | Automatic shelf registration | Dec 16, 2022 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Dec 6, 2022 | Dec 5, 2022 |
| 10-Q | Quarterly report | Oct 27, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 27, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Oct 27, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2022 | Oct 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 7, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Other events
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| S-8 | Employee stock plan registration | Jun 23, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Jun 9, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
May 27, 2022 | May 24, 2022 |
| 10-Q | Quarterly report | May 3, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 3, 2022 | May 3, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 8, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2022 | Jun 8, 2022 |
| S-8 POS | Filing | Apr 13, 2022 | — |
| 10-K | Annual report | Feb 22, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 22, 2022 | Feb 22, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jan 10, 2022 | Jan 7, 2022 |
| S-8 | Employee stock plan registration | Jan 5, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2021 | Nov 30, 2021 |
| 10-Q | Quarterly report | Oct 28, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 28, 2021 | Oct 28, 2021 |
| UPLOAD | Letter from the SEC | Oct 27, 2021 | — |
| CORRESP | Letter to the SEC | Oct 19, 2021 | — |
| CT ORDER | Filing | Oct 19, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2021 | — |
| CORRESP | Letter to the SEC | Sep 23, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2021 | Sep 23, 2021 |
| UPLOAD | Letter from the SEC | Aug 26, 2021 | — |
| 10-Q | Quarterly report | Jul 29, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Shareholder vote results
|
Jun 9, 2021 | Jun 8, 2021 |
| 10-Q | Quarterly report | May 4, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 4, 2021 | May 4, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 8, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2021 | Apr 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 15, 2021 | Apr 15, 2021 |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 4, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| POSASR | Filing | Jan 7, 2021 | — |
| POSASR | Form posasr | Jan 7, 2021 | — |
| S-8 | Employee stock plan registration | Jan 4, 2021 | — |
| 10-Q | Quarterly report | Oct 29, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2020 | Oct 29, 2020 |
| CT ORDER | Filing | Sep 17, 2020 | — |
| 8-K |
Current report
Other events
|
Aug 21, 2020 | Aug 21, 2020 |
| 424B5 | Prospectus supplement | Aug 21, 2020 | — |
| 8-K |
Current report
Other events
|
Aug 11, 2020 | Aug 10, 2020 |
| 424B5 | Prospectus supplement | Aug 11, 2020 | — |
| S-3ASR | Automatic shelf registration | Aug 10, 2020 | — |
| 8-K |
Current report
Other events
|
Aug 7, 2020 | Aug 7, 2020 |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 20, 2020 | Jul 17, 2020 |
| CT ORDER | Filing | Jul 15, 2020 | — |
| 8-K |
Current report
Agreement ended
|
Jul 2, 2020 | Jul 1, 2020 |
| S-3ASR | Automatic shelf registration | Jun 19, 2020 | — |
| D | Filing | Jun 12, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2020 | Jun 10, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jun 4, 2020 | May 29, 2020 |
| DEFA14A | Additional proxy material | May 28, 2020 | — |
| D | Filing | May 14, 2020 | — |
| S-3ASR | Automatic shelf registration | May 7, 2020 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 6, 2020 | May 5, 2020 |
| 10-Q | Quarterly report | Apr 30, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 30, 2020 | Apr 29, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 30, 2020 | Apr 30, 2020 |
| DEFA14A | Additional proxy material | Apr 27, 2020 | — |
| DEF 14A | Proxy statement | Apr 27, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2020 | Apr 17, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 16, 2020 | Mar 11, 2020 |
| 10-K | Annual report | Mar 2, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 2, 2020 | Mar 2, 2020 |
| SEC STAFF LETTER | Filing | Feb 18, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 7, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 17, 2020 | Jan 15, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| S-8 | Employee stock plan registration | Jan 6, 2020 | — |
| CT ORDER | Filing | Nov 7, 2019 | — |
| 10-Q | Quarterly report | Oct 30, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale
|
Oct 30, 2019 | Oct 25, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 30, 2019 | Oct 29, 2019 |
| UPLOAD | Letter from the SEC | Oct 18, 2019 | — |
| CORRESP | Letter to the SEC | Oct 9, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2019 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 20, 2019 | Sep 17, 2019 |
| 424B5 | Prospectus supplement | Sep 19, 2019 | — |
| FWP | Free writing prospectus | Sep 18, 2019 | — |
| 424B5 | Prospectus supplement | Sep 17, 2019 | — |
| 424B5 | Prospectus supplement | Aug 7, 2019 | — |
| 8-K |
Current report
Material agreement
|
Aug 7, 2019 | Aug 7, 2019 |
| 10-Q | Quarterly report | Aug 6, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Aug 5, 2019 | Aug 4, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2019 | Jun 12, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 3, 2019 | May 31, 2019 |
| 10-Q | Quarterly report | May 2, 2019 | Mar 31, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Warren, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1070081
- Former names
- PTC THERAPEUTICS INC (until Oct 12, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.